198 related articles for article (PubMed ID: 10228288)
1. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants.
Tammela O; Ojala R; Iivainen T; Lautamatti V; Pokela ML; Janas M; Koivisto M; Ikonen S
J Pediatr; 1999 May; 134(5):552-7. PubMed ID: 10228288
[TBL] [Abstract][Full Text] [Related]
2. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
Herrera C; Holberton J; Davis P
Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
[TBL] [Abstract][Full Text] [Related]
3. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
Herrera C; Holberton J; Davis P
Cochrane Database Syst Rev; 2007 Apr; 2007(2):CD003480. PubMed ID: 17443527
[TBL] [Abstract][Full Text] [Related]
4. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
5. Duration of indomethacin treatment of the preterm patent ductus arteriosus as directed by echocardiography.
Carmo KB; Evans N; Paradisis M
J Pediatr; 2009 Dec; 155(6):819-822.e1. PubMed ID: 19643435
[TBL] [Abstract][Full Text] [Related]
6. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
[TBL] [Abstract][Full Text] [Related]
7. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
Malviya M; Ohlsson A; Shah S
Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
Quinn D; Cooper B; Clyman RI
Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
[TBL] [Abstract][Full Text] [Related]
10. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants.
Lee J; Rajadurai VS; Tan KW; Wong KY; Wong EH; Leong JY
Pediatrics; 2003 Aug; 112(2):345-50. PubMed ID: 12897285
[TBL] [Abstract][Full Text] [Related]
12. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
13. Use of echocardiography to guide the duration of indomethacin treatment of patent ductus arteriosus in preterm infants.
Bajaj R; Narasimhan R
J Pediatr; 2010 Aug; 157(2):346; author reply 346. PubMed ID: 20553839
[No Abstract] [Full Text] [Related]
14. Therapeutic closure of the ductus arteriosus: benefits and limitations.
Mercanti I; Boubred F; Simeoni U
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
[TBL] [Abstract][Full Text] [Related]
15. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
[TBL] [Abstract][Full Text] [Related]
16. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
Keller RL; Clyman RI
Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus.
Attridge JT; Kaufman DA; Lim DS
Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F178-82. PubMed ID: 18981033
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.
Yadav S; Agarwal S; Maria A; Dudeja A; Dubey NK; Anand P; Yadav DK
Pediatr Cardiol; 2014 Jun; 35(5):824-30. PubMed ID: 24435507
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin dosing strategy and neonatal patent ductus arteriosus closure.
Rathi P; Messina C; Mintzer JP
J Neonatal Perinatal Med; 2019; 12(4):411-417. PubMed ID: 31561393
[TBL] [Abstract][Full Text] [Related]
20. Use of acetaminophen for patent ductus arteriosus treatment: a single center experience.
Vaidya R; Wilson D; Paris Y; Madore L; Singh R
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2723-2729. PubMed ID: 30563380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
